NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...

The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

Arthropod-borne diseases such as Dengue, Chikungunya, Malaria (caused by Plasmodium spp.), and Zika are endemic and re-emerging infections in tropical and subtropical regions. During heavy monsoon ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer The National Cancer Institute-Molecular ...

Seegene Inc. , a leading developer of multiplex PCR technologies, today announced that it has been issued a United States Patent, No. 8,809,239, for its tagging oligonucleotide capture and extension ...

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...